Error: Could not add to watchlist. X
+ Watchlist

BB Adamant Global Biotech

ADGLBII:SW
2,905.19
CHF
14.09
0.48%
As of 12:08 PM EDT 4/21/2017
Fund Type
Open-End Fund
52Wk Range
2,279.21 - 3,060.58
1 Yr Return
1.80%
YTD Return
11.17%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Previous Close
2,919.28
52Wk Range
2,279.21 - 3,060.58
1 Yr Return
1.20%
YTD Return
11.17%
Fund Type
Open-End Fund
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
Global
NAV (on 04/21/2017)
2,905.19
Total Assets (m CHF) (on 04/21/2017)
108.653
Inception Date
10/15/2010
Last Dividend (on 01/18/2017)
-
Dividend Indicated Gross Yield
-
Fund Managers
JOHN MANIERI
Front Load Fee
1.20%
Back Load Fee
1.00%
Redemption Fee
1.00%
12b-1 Fee
-
Current Mgmt Fee
1.20%
Expense Ratio
1.22%

Top Fund Holdings

Name Position Value % of Fund
36.80 k 10.31 m 8.50
94.00 k 10.19 m 8.40
55.00 k 9.14 m 7.54
20.00 k 8.22 m 6.77
94.00 k 7.22 m 5.95
32.00 k 5.14 m 4.24
57.00 k 4.97 m 4.10
52.00 k 4.87 m 4.02
31.00 k 3.85 m 3.17
40.00 k 3.84 m 3.17
Profile
BB Adamant Global Biotech is an open-end fund incorporated in Switzerland. The objective of the Fund is to obtain long-term capital growth with active management. The Fund invests on a global basis in the shares of companies in the biotech sector.
Address
Swisscanto Fondsleitung AG
Bahnhofstrasse 9
8001 Zuerich
Switzerland
Phone
Tel: +41 58 344 49 00